{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T23:16:15Z","timestamp":1792278975682,"version":"4.4.0"},"reference-count":70,"publisher":"Oxford University Press (OUP)","issue":"suppl_3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI103055"],"award-info":[{"award-number":["AI103055"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI099243"],"award-info":[{"award-number":["AI099243"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10,15]]},"DOI":"10.1093\/infdis\/jiy414","type":"journal-article","created":{"date-parts":[[2018,8,4]],"date-time":"2018-08-04T15:08:51Z","timestamp":1533395331000},"page":"S141-S146","source":"Crossref","is-referenced-by-count":60,"title":["Cholera: Immunity and Prospects in Vaccine Development"],"prefix":"10.1093","volume":"218","author":[{"given":"Jason B","family":"Harris","sequence":"first","affiliation":[{"name":"Division of Pediatric Global Health, Massachusetts General Hospital, Boston, Massachusetts"},{"name":"Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts"},{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,9,1]]},"reference":[{"key":"key\n\t\t\t\t20181015112356778_CIT0001","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nature10392","article-title":"Evidence for several waves of global transmission in the seventh cholera pandemic","volume":"477","author":"Mutreja","year":"2011","journal-title":"Nature"},{"key":"key\n\t\t\t\t20181015112356778_CIT0002","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0140-6736(17)30559-7","article-title":"Cholera","volume":"390","author":"Clemens","year":"2017","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20181015112356778_CIT0003","doi-asserted-by":"crossref","first-page":"e0004183","DOI":"10.1371\/journal.pntd.0004183","article-title":"Vibrio cholerae serogroup O139: isolation from cholera patients and asymptomatic household family members in Bangladesh between 2013 and 2014","volume":"9","author":"Chowdhury","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20181015112356778_CIT0004","doi-asserted-by":"crossref","first-page":"10374","DOI":"10.1073\/pnas.92.22.10374","article-title":"Genetic rearrangements in the rfb regions of Vibrio cholerae O1 and O139","volume":"92","author":"Stroeher","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20181015112356778_CIT0005","doi-asserted-by":"crossref","first-page":"e0005044","DOI":"10.1371\/journal.pntd.0005044","article-title":"Retrospective analysis of serotype switching of Vibrio cholerae O1 in a cholera endemic region shows it is a non-random process","volume":"10","author":"Karlsson","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20181015112356778_CIT0006","doi-asserted-by":"crossref","first-page":"e1004405","DOI":"10.1371\/journal.ppat.1004405","article-title":"Insights into Vibrio cholerae intestinal colonization from monitoring fluorescently labeled bacteria","volume":"10","author":"Millet","year":"2014","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20181015112356778_CIT0007","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00594-17","article-title":"Analysis of the human mucosal response to cholera reveals sustained activation of innate immune signaling pathways","volume":"86","author":"Bourque","year":"2018","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20181015112356778_CIT0008","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1084\/jem.168.4.1487","article-title":"Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans","volume":"168","author":"Herrington","year":"1988","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20181015112356778_CIT0009","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1126\/science.272.5270.1910","article-title":"Lysogenic conversion by a filamentous phage encoding cholera toxin","volume":"272","author":"Waldor","year":"1996","journal-title":"Science"},{"key":"key\n\t\t\t\t20181015112356778_CIT0010","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/MMBR.47.4.510-550.1983","article-title":"New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development","volume":"47","author":"Levine","year":"1983","journal-title":"Microbiol Rev"},{"key":"key\n\t\t\t\t20181015112356778_CIT0011","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/infdis\/143.6.818","article-title":"Duration of infection-derived immunity to cholera","volume":"143","author":"Levine","year":"1981","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20181015112356778_CIT0012","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/infdis\/jir416","article-title":"Natural cholera infection-derived immunity in an endemic setting","volume":"204","author":"Ali","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20181015112356778_CIT0013","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/oxfordjournals.aje.a113498","article-title":"Endemic cholera in rural Bangladesh, 1966\u20131980","volume":"116","author":"Glass","year":"1982","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20181015112356778_CIT0014","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1093\/infdis\/136.Supplement.S105","article-title":"Mechanisms of disease and immunity in cholera: a review","volume":"136","author":"Holmgren","year":"1977","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20181015112356778_CIT0015","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02021-16","article-title":"Single-cell analysis of the plasmablast response to Vibrio cholerae demonstrates expansion of cross-reactive memory B cells","volume":"7","author":"Kauffman","year":"2016","journal-title":"MBio"},{"key":"key\n\t\t\t\t20181015112356778_CIT0016","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/infdis\/jix253","article-title":"Plasma and mucosal immunoglobulin M, immunoglobulin A, and immunoglobulin G responses to the Vibrio cholerae O1 protein immunome in adults with cholera in Bangladesh","volume":"216","author":"Charles","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20181015112356778_CIT0017","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1371\/journal.pntd.0000221","article-title":"Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh","volume":"2","author":"Harris","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20181015112356778_CIT0018","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1128\/CVI.00037-12","article-title":"Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh","volume":"19","author":"Patel","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20181015112356778_CIT0019","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.vaccine.2018.04.011","article-title":"Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection","volume":"36","author":"Haney","year":"2018","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20181015112356778_CIT0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0035-9203(79)90119-6","article-title":"Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity","volume":"73","author":"Levine","year":"1979","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t20181015112356778_CIT0021","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0140-6736(90)90080-O","article-title":"Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up","volume":"335","author":"Clemens","year":"1990","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20181015112356778_CIT0022","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/cid\/ciw145","article-title":"Single-dose live oral cholera vaccine CVD 103-HgR protects against human experimental infection with Vibrio cholerae O1 El Tor","volume":"62","author":"Chen","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181015112356778_CIT0023","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/infdis\/121.5.505","article-title":"The antigens of Vibrio cholerae involved in the vibriocidal action of antibody and complement","volume":"121","author":"Neoh","year":"1970","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20181015112356778_CIT0024","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1128\/CVI.00321-12","article-title":"Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera","volume":"19","author":"Johnson","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20181015112356778_CIT0025","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1086\/421275","article-title":"Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh","volume":"189","author":"Saha","year":"2004","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20181015112356778_CIT0026","article-title":"Immunity provided by an outer membrane vesicle cholera vaccine is due to O-antigen-specific antibodies inhibiting bacterial motility","volume":"85","author":"Wang","year":"2016","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20181015112356778_CIT0027","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1016\/j.vaccine.2016.10.023","article-title":"A monoclonal antibody that targets the conserved core\/lipid A region of lipopolysaccharide affects motility and reduces intestinal colonization of both classical and El Tor Vibrio cholerae biotypes","volume":"34","author":"Levinson","year":"2016","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20181015112356778_CIT0028","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1128\/CVI.00481-10","article-title":"Mucosal immunologic responses in cholera patients in Bangladesh","volume":"18","author":"Uddin","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20181015112356778_CIT0029","first-page":"516","article-title":"Jaime Ferran and preventive inoculation against cholera","volume":"55","author":"Bornside","year":"1981","journal-title":"Bull Hist Med"},{"key":"key\n\t\t\t\t20181015112356778_CIT0030","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2310\/7060.2001.24300","article-title":"Cholera vaccines","volume":"8","author":"Ryan","year":"2001","journal-title":"J Travel Med"},{"key":"key\n\t\t\t\t20181015112356778_CIT0031","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/infdis\/158.1.60","article-title":"Field trial of oral cholera vaccines in Bangladesh: results of one year of follow-up","volume":"158","author":"Clemens","year":"1988","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20181015112356778_CIT0032","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0264-410X(95)00122-H","article-title":"Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up","volume":"14","author":"van Loon","year":"1996","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20181015112356778_CIT0033","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(86)91944-6","article-title":"Field trial of oral cholera vaccines in Bangladesh","volume":"2","author":"Clemens","year":"1986","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20181015112356778_CIT0034","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1128\/CVI.05615-11","article-title":"Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh","volume":"19","author":"Leung","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20181015112356778_CIT0035","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1128\/CVI.05088-11","article-title":"Vibrio cholerae O1 infection induces proinflammatory CD4+ T-cell responses in blood and intestinal mucosa of infected humans","volume":"18","author":"Kuchta","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20181015112356778_CIT0036","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(88)92189-7","article-title":"Impact of B subunit killed whole-cell and killed whole-cell-only oral vaccines against cholera upon treated diarrhoeal illness and mortality in an area endemic for cholera","volume":"1","author":"Clemens","year":"1988","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20181015112356778_CIT0037","doi-asserted-by":"crossref","first-page":"8285","DOI":"10.1016\/j.vaccine.2011.08.108","article-title":"Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age","volume":"29","author":"Saha","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20181015112356778_CIT0038","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.vaccine.2016.02.020","article-title":"The oral cholera vaccine Shanchol when stored at elevated temperatures maintains the safety and immunogenicity profile in Bangladeshi participants","volume":"34","author":"Saha","year":"2016","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20181015112356778_CIT0039","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S1473-3099(13)70273-1","article-title":"5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial","volume":"13","author":"Bhattacharya","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20181015112356778_CIT0040","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S1473-3099(17)30359-6","article-title":"Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis","volume":"17","author":"Bi","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20181015112356778_CIT0041","doi-asserted-by":"crossref","first-page":"e2828","DOI":"10.1371\/journal.pntd.0002828","article-title":"Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti","volume":"8","author":"Charles","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20181015112356778_CIT0042","doi-asserted-by":"crossref","first-page":"482","DOI":"10.15585\/mmwr.mm6618a6","article-title":"Recommendations of the Advisory Committee on Immunization Practices for use of cholera vaccine","volume":"66","author":"Wong","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20181015112356778_CIT0043","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(88)90120-1","article-title":"Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR","volume":"2","author":"Levine","year":"1988","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20181015112356778_CIT0044","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1128\/IAI.67.12.6341-6345.1999","article-title":"Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination","volume":"67","author":"Tacket","year":"1999","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20181015112356778_CIT0045","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0140-6736(92)92231-4","article-title":"Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5\u20139-year-old Indonesian children","volume":"340","author":"Suharyono","year":"1992","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20181015112356778_CIT0046","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/j.vaccine.2003.11.070","article-title":"Can oral cholera vaccination play a role in controlling a cholera outbreak","volume":"22","author":"Calain","year":"2004","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20181015112356778_CIT0047","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/S0264-410X(00)00006-2","article-title":"Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area","volume":"18","author":"Richie","year":"2000","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20181015112356778_CIT0048","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/cid\/ciw149","article-title":"Editorial commentary: resurrecting a live oral cholera vaccine","volume":"62","author":"Harris","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181015112356778_CIT0049","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1371\/journal.pntd.0000173","article-title":"The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa","volume":"2","author":"Deen","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20181015112356778_CIT0050","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CVI.00035-13","article-title":"Immune responses to the O-specific polysaccharide antigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in Bangladesh","volume":"20","author":"Leung","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20181015112356778_CIT0051","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/CVI.00532-10","article-title":"The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines","volume":"18","author":"Thiem","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20181015112356778_CIT0052","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20181015112356778_CIT0053","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/IAI.66.7.3095-3099.1998","article-title":"Phase 1 evaluation of Vibrio cholerae O1, serotype Inaba, polysaccharide-cholera toxin conjugates in adult volunteers","volume":"66","author":"Gupta","year":"1998","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20181015112356778_CIT0054","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/cbic.201600699","article-title":"Conjugate vaccines from bacterial antigens by squaric acid chemistry: a closer look","volume":"18","author":"Xu","year":"2017","journal-title":"Chembiochem"},{"key":"key\n\t\t\t\t20181015112356778_CIT0055","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1021\/bc2001984","article-title":"Simple, direct conjugation of bacterial O-SP-core antigens to proteins: development of cholera conjugate vaccines","volume":"22","author":"Xu","year":"2011","journal-title":"Bioconjug Chem"},{"key":"key\n\t\t\t\t20181015112356778_CIT0056","doi-asserted-by":"crossref","first-page":"e0003881","DOI":"10.1371\/journal.pntd.0003881","article-title":"A cholera conjugate vaccine containing O-specific polysaccharide (OSP) of V. cholerae O1 inaba and recombinant fragment of tetanus toxin heavy chain (OSP:rTTHc) induces serum, memory and lamina proprial responses against OSP and is protective in mice","volume":"9","author":"Sayeed","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20181015112356778_CIT0057","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/mi.2017.70","article-title":"Adjuvant selection regulates gut migration and phenotypic diversity of antigen-specific CD4+ T cells following parenteral immunization","volume":"11","author":"Frederick","year":"2018","journal-title":"Mucosal Immunol"},{"key":"key\n\t\t\t\t20181015112356778_CIT0058","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00470-16","article-title":"The live attenuated cholera vaccine CVD 103-HgR primes responses to the toxin-coregulated pilus antigen TcpA in subjects challenged with wild-type Vibrio cholerae","volume":"24","author":"Mayo-Smith","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20181015112356778_CIT0059","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/infdis\/172.4.1126","article-title":"Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1","volume":"172","author":"Kenner","year":"1995","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20181015112356778_CIT0060","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap8423","article-title":"A live vaccine rapidly protects against cholera in an infant rabbit model","volume":"10","author":"Hubbard","year":"2018","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t20181015112356778_CIT0061","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat9483","article-title":"Curbing cholera","volume":"10","author":"Hall","year":"2018","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t20181015112356778_CIT0062","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.1016\/j.vaccine.2011.06.121","article-title":"Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens","volume":"29","author":"Lebens","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20181015112356778_CIT0063","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3389\/fmicb.2015.00823","article-title":"A combined vaccine approach against Vibrio cholerae and ETEC based on outer membrane vesicles","volume":"6","author":"Leitner","year":"2015","journal-title":"Front Microbiol"},{"key":"key\n\t\t\t\t20181015112356778_CIT0064","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1128\/IAI.00532-08","article-title":"Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice","volume":"76","author":"Schild","year":"2008","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20181015112356778_CIT0065","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0140-6736(16)31529-X","article-title":"Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study","volume":"388","author":"Liu","year":"2016","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20181015112356778_CIT0066","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ebiom.2017.02.024","article-title":"Causal pathways from enteropathogens to environmental enteropathy: findings from the MAL-ED birth cohort study","volume":"18","author":"Kosek","year":"2017","journal-title":"EBioMedicine"},{"key":"key\n\t\t\t\t20181015112356778_CIT0067","doi-asserted-by":"crossref","first-page":"625","DOI":"10.4269\/ajtmh.13-0170","article-title":"Predictors of disease severity in patients admitted to a cholera treatment center in urban Haiti","volume":"89","author":"Valcin","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20181015112356778_CIT0068","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-3156.2008.02051.x","article-title":"Is HIV infection associated with an increased risk for cholera? Findings from a case-control study in Mozambique","volume":"13","author":"von Seidlein","year":"2008","journal-title":"Trop Med Int Health"},{"key":"key\n\t\t\t\t20181015112356778_CIT0069","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/infdis\/jiv108","article-title":"Immunogenicity of the bivalent oral cholera vaccine Shanchol in Haitian adults with HIV infection","volume":"212","author":"Ivers","year":"2015","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20181015112356778_CIT0070","first-page":"63","article-title":"A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali","volume":"76","author":"Perry","year":"1998","journal-title":"Bull World Health Organ"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/218\/suppl_3\/S141\/26065127\/jiy414.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T15:42:03Z","timestamp":1661701323000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/218\/suppl_3\/S141\/5089248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":70,"journal-issue":{"issue":"suppl_3","published-online":{"date-parts":[[2018,9,1]]},"published-print":{"date-parts":[[2018,10,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy414","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733951530.793558867","asserted-by":"object"}]},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11,15]]},"published":{"date-parts":[[2018,9,1]]}}}